Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.

ABSTRACT: Despite marked improvements in the modern treatment era, human immunodeficiency virus (HIV)-infected individuals, particularly those who initiated antiretroviral therapy (ART) at advanced disease stages, continue to have increased age-related morbidity and mortality, compared with the general population. Immune activation and inflammation persist despite suppressive ART and predict many of these morbidities. The goal of this review is to examine the evidence suggesting a link between the persistent inflammatory state and morbidity and mortality in this setting, to describe the impact of early ART initiation on these factors, and to highlight important unanswered questions for the field. We also advance a hypothesis to explain why some morbidities-and their root inflammatory drivers-may be

SUBMITTER: Hunt PW 

PROVIDER: S-EPMC5021241 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature